Pre-injection Testing Sample Clauses

Pre-injection Testing. Prior to the first injection of Biomethane into NW Natural’s LDC System, or other NW Natural owned and operated facilities, the Producer will hire an independent certified third party laboratory (Oregon Environmental Laboratory Accreditation Program [ORELAP] certified, or equivalent in another state, where applicable) to perform two pre-injection tests. Samples for each test will be taken a minimum of fourteen (14) calendar days apart and from the flow of gas to the Receipt Point Facilities prior to receipt of Biomethane at the Receipt Point Facilities. Producer shall provide NW Natural with a minimum of two (2) business days’ advance notice of the Biomethane sampling and NW Natural shall have the option to have a representative present to observe the samples being taken. Samples shall be tested for all Constituents specified in Table 1 in Exhibit C according to the feedstock. Test results shall be shared with NW Natural within five (5) business days of Producer's receipt of the test results.
AutoNDA by SimpleDocs
Pre-injection Testing. Prior to the first injection of Biomethane into the LDC System, or other NW Natural owned and operated facilities, Producer will hire an independent certified third party laboratory (Oregon Environmental Laboratory Accreditation Program [ORELAP] certified, or equivalent in another state, where applicable) to perform two pre-injection tests (“Pre-Injection Testing”). Samples for each test will be taken a minimum of fourteen (14) days apart and from the flow of gas to the Receipt Point Facilities prior to receipt of Biomethane at the Receipt Point Facilities. Producer will provide NW Natural with a minimum of two (2) business days’ advance notice of the Biomethane sampling and NW Natural will have the option to have a representative present to observe the samples being taken. Samples will be tested for all Constituents specified in Table 1 in Exhibit C according to the feedstock. Test results will be shared with NW Natural within five (5) business days of Producer's receipt of the test results. Producer is responsible for identifying an independent third-party certified laboratory that is capable of detecting constituents at levels specified in Table 1 – Constituent Concentrations, attached in Exhibit C. NW Natural reserves the right to specify a certified laboratory in the event Producer is unable to do so. Test results from the second pre-injection test will identify the Group 1 and Group 2 Health Constituents for Periodic Testing. During Pre-Injection Testing, the Biomethane’s collective potential cancer risk and non-cancer risk totals will be calculated for the Group 2 Health Constituents: Cancer Risk: the sum of the ratios for each carcinogenic constituent measured over the Trigger Level identified in Table 1 in Exhibit C. The ratio is the measured value divided by the trigger level (See formula in Table 2 in Exhibit C). Non-Cancer Risk: the sum of the health indexes of each non-carcinogenic constituent that registers over the Trigger Level identified in Table 1 in Exhibit C. The health index is the measured value divided by the Trigger Level multiplied by 0.1 (See formula in Table 2 in Exhibit C). If the collective potential cancer risk or non-cancer risk is at or above the Risk Level A values defined in Table 2 - Collective Risk from Carcinogenic and Non-carcinogenic Constituents, attached in Exhibit C, the Biomethane cannot be accepted or transported by the LDC System. Producer will make necessary modifications to lower the collective potential cance...

Related to Pre-injection Testing

  • ODUF Testing 6.6.1 Upon request from TWTC, AT&T shall send ODUF test files to TWTC. The Parties agree to review and discuss the ODUF file content and/or format. For testing of usage results, AT&T shall request that TWTC set up a production (live) file. The live test may consist of TWTC’s employees making test calls for the types of services TWTC requests on ODUF. These test calls are logged by TWTC, and the logs are provided to AT&T. These logs will be used to verify the files. Testing will be completed within thirty (30) days from the date on which the initial test file was sent.

  • Drug Testing (A) The state and the PBA agree to drug testing of employees in accordance with section 112.0455, F.S., the Drug-Free Workplace Act.

  • Substance Abuse Testing The Parties agree that it is in the best interest of all concerned to promote a safe working environment. The Union has no objection to pre-employment substance abuse testing when required by the Employer and further, the Union has no objection to voluntary substance abuse testing to qualify for employment on projects when required by a project owner. The cost and scheduling of such testing shall be paid for and arranged by the Employer. The Union agrees to reimburse the Employer for any failed pre-access Alcohol and Drug test costs.

  • INSPECTION/TESTING All Products sold pursuant to this Agreement will be subject to inspection/testing by or at the direction of H- GAC and/or the ordering Customer, either at the delivery destination or the place of manufacture. In the event a Product fails to meet or exceed all requirements of this Agreement, and unless otherwise agreed in advance, the cost of any inspection and/or testing, will be the responsibility of the Contractor.

  • Repair Testing At the time of repair of a LIS trunk group, at no additional charge, tests will be performed to ensure that the service is operational and meets the applicable technical parameters.

  • Random Testing Notwithstanding any provisions of the Collective Agreement or any special agreements appended thereto, section 4.6 of the Canadian Model will not be applied by agreement. If applied to a worker dispatched by the Union, it will be applied or deemed to be applied unilaterally by the Employer. The Union retains the right to grieve the legality of any imposition of random testing in accordance with the Grievance Procedure set out in this Collective Agreement.

  • Random Drug Testing All employees covered by this Agreement shall be subject to random drug testing in accordance with Appendix D.

  • Testing Landlord shall have the right to conduct annual tests of the Premises to determine whether any contamination of the Premises or the Project has occurred as a result of Tenant’s use. Tenant shall be required to pay the cost of such annual test of the Premises; provided, however, that if Tenant conducts its own tests of the Premises using third party contractors and test procedures acceptable to Landlord which tests are certified to Landlord, Landlord shall accept such tests in lieu of the annual tests to be paid for by Tenant. In addition, at any time, and from time to time, prior to the expiration or earlier termination of the Term, Landlord shall have the right to conduct appropriate tests of the Premises and the Project to determine if contamination has occurred as a result of Tenant’s use of the Premises. In connection with such testing, upon the request of Landlord, Tenant shall deliver to Landlord or its consultant such non-proprietary information concerning the use of Hazardous Materials in or about the Premises by Tenant or any Tenant Party. If contamination has occurred for which Tenant is liable under this Section 30, Tenant shall pay all costs to conduct such tests. If no such contamination is found, Landlord shall pay the costs of such tests (which shall not constitute an Operating Expense). Landlord shall provide Tenant with a copy of all third party, non-confidential reports and tests of the Premises made by or on behalf of Landlord during the Term without representation or warranty and subject to a confidentiality agreement. Tenant shall, at its sole cost and expense, promptly and satisfactorily remediate any environmental conditions identified by such testing in accordance with all Environmental Requirements. Landlord’s receipt of or satisfaction with any environmental assessment in no way waives any rights which Landlord may have against Tenant.

  • Drug Test The compulsory production and submission of urine and/or blood, in accordance with departmental procedures, by an employee for chemical analysis to detect prohibited drug usage.

  • Meter Testing Company shall provide at least twenty-four (24) hours' notice to Seller prior to any test it may perform on the revenue meters or metering equipment. Seller shall have the right to have a representative present during each such test. Seller may request, and Company shall perform, if requested, tests in addition to the every fifth-year test and Seller shall pay the cost of such tests. Company may, in its sole discretion, perform tests in addition to the fifth year test and Company shall pay the cost of such tests. If any of the revenue meters or metering equipment is found to be inaccurate at any time, as determined by testing in accordance with this Section 10.2 (Meter Testing), Company shall promptly cause such equipment to be made accurate, and the period of inaccuracy, as well as an estimate for correct meter readings, shall be determined in accordance with Section 10.3 (Corrections).

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!